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 Abstract 
Introduction: Sleep disorders can go undiagnosed if a provider is not asking the right questions; 
they can be characterized by loud snoring with apneic episodes that never fully wake the person, 
difficulty falling asleep or daytime fatigue. Poor sleep can affect activities of daily living, job 
performance and personal relationships. Poor sleep can be difficult to detect because some may 
consider it a symptom because of their lifestyle. The purpose of this study is to assess 
participants sleep quality and functional outcomes of poor sleep.  
Methods: Primary care providers have an opportunity to screen for sleep disorders as part of the 
intake process during an office visit. The Functional Outcomes of Sleep Questionnaire (FOSQ), 
has been proposed as guide to determine if a sleep disorder is affecting quality of life.  This 
descriptive study randomly recruited 20 participants from a community health center. A 10-
question survey was given to individuals over the age of 18 who can write and speak English and 
either have a body mass index (BMI) over 30, hypertension (HTN) or diabetes type II (DMII).  
Demographic information evaluated included age, gender, HTN, DMII, BMI>30, marital status, 
sleeping alone, employment type, race, type of insurance, how many times do they wake up at 
night, the average number of hours slept per night and does the person work night shift. 
Results: The study used a qualitative approach with a descriptive methodology; statistical 
analysis consisted of proportions, means and standard deviation to describe the study population. 
Participant age ranged from 33 to 72 years (M=50.1, SD= 11.32).  Sixty percent were both 
female and married/living with partner. Despite being married/living with partner, 50% slept 
alone.  A Mann-Whitney U test showed that there was a significant difference in four of the 
questions in the FOSQ-10 in which functional outcomes were not affected by being sleepy or 
tired. 
Conclusion: The FOSQ-10 may serve a role in identifying patients who might benefit from a 
sleep study.  The inclusion of a sleep disorder screening tool may increase the specificity and 
sensitivity of the intervention and the ability to yield data that will objectively measure 
disordered sleep.  
 
Keywords: sleep apnea, sleep apnea screening, primary care provider, hypertension, diabetes, 
sleep disorder, impaired quality of life, quality of life screening 
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Sleep Quality and the Effect on Functional Outcomes 
Sleep apnea can be described as a temporary pause in breathing while someone sleeps 
that lasts from ten to ninety seconds. Symptoms include daytime fatigue, difficulty falling asleep 
and difficulty staying asleep. Insomnia is characterized by difficulty falling asleep, staying asleep 
or going back to sleep. Narcolepsy is a described as daytime sleepiness or unable to stay awake 
during the daytime. What do these conditions all have in common? They are all considered sleep 
disorders. Treatment for sleep disorders includes medication, positive airway pressure devices, 
oral appliances, behavioral treatments and/or surgery (Epstein, et al., 2009; Garg, 2018). The 
benefits of treatment include reduced hemoglobin A1c (HbA1c) in diabetes mellitus type 2 
(DMII), a decrease in daytime drowsiness, decrease in hypertension (HTN) and a decrease in 
disturbed sleep which can result in an improved quality of life. Having untreated sleep disorders 
increases the chances of developing other conditions that can affect the social, mental and 
physical health of a person, thereby affecting self-care, personal relationships and employment. 
Fatigue during the day has been shown to affect employment performance, personal relationships 
and activities of daily living and mental health (Guglielmi, Magnavita, & Garbarino, 2017; 
Appleton, et al., 2018). Sleep disorders also contribute to cognitive impairment, loss in work 
productivity due to injury, and an increase risk of automobile crashes (Hiestand, Britz, Goldman, 
& Phillips, 2006; Leng, McEvoy, & Allen, 2017). 
Background and Significance 
Sleep disorders can be considered a life-threatening condition that affects approximately 
17% of population in the United States (Goodson, Wung, & Hedger Archbold, 2012). According 
to the American Academy of Sleep Medicine (2015), undiagnosed sleep disorders cost the U.S. 
$150 million in 2015. The consequences have been associated with diabetes, hypertension, 
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obesity and quality of life (Babu, Herdegen, Fogelfeld, & Shott, 2005; Kemple, O'Toole, & 
O'Toole, 2015; Priou, et al., 2015).  
Those who have interrupted sleep are more likely to gain weight and have increased risk 
of developing obstructive sleep apnea (OSA). Data suggests that the sleep disruption and 
intermittent hypoxia can decrease insulin sensitivity, worsen glucose tolerance, create insulin 
resistance and pancreatic -cell dysfunction increasing risk for diabetes or contributing to 
diabetic complications (Raju, Swaroopa, Yadati, & Alekhya, 2016; Rajan & Greenberg, 2015). 
The National Institute of Diabetes and Digestive and Kidney Diseases (2018) reports risk factors 
that contribute to insulin resistance include large waist size, elevated triglycerides, elevated 
cholesterol, HTN and fasting blood glucose level of >100mg/dl. It can also be noted that sleep 
disorder patients with insulin resistance are at an increased risk of diabetes mellitus (Malik, 
Masoodi, & Shoib, 2017; Sahin, et al., 2011). 
In a prospective analysis of 1,453 non-diabetic participants, severe OSA was associated 
with a 71% increased risk of diabetes. This was independent of any other risk factors including 
BMI and waist circumference (Nagayoshi, 2016; Ford, Cunningham, Giles, & Croft, 2015). 
Untreated sleep disorders in diabetics are associated with poor glycemic control that results in 
use of medication that has side effects of weight gain, thereby exacerbating the severity of sleep 
disorders and increasing cardiovascular risk (Malik, Masoodi, & Shoib, 2017; Reutrakul & 
Mokhlesi, 2017).  
The association between sleep disorders and HTN is just as significant. In 2012 
cardiovascular diseases cost the United States an average of $317 billion (CDC, 2016). The 
constant upper airway obstruction contributes to intermittent hypoxia and hypercapnia which 
increases blood pressure and stresses the cardiovascular system (Windland-Brown & Porter, 
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2011). Evidence suggests that the repeated strain on the heart and the circulatory system 
throughout the night causes a sympathetic nervous system response that can persist during the 
day. These patients tend to have higher heart rates, higher blood pressure and arterial stiffness 
(Knauert, Naik, Gillespie, & Kryger, 2015). 
In a study by Kasei, Floras and Bradley (2012), it was found that in 65% to 80% of the 
drug resistant HTN cases, a sleep disorder was present.  In general, when there are repeated 
apnea events the heart and circulatory system are exposed to harmful stimuli that may initiate or 
contribute to the progression of cardiovascular disorders that include heart failure, arrhythmias 
and stroke (Kasai, Floras, & Bradley, 2012).  In a cohort study by Gami, et al., (2013), 10,701 
adults were followed, and the risk of sudden cardiac death after five years was associated with 
OSA, this was based not only on the frequency of apnea levels but the severity of oxygen 
desaturation while sleeping.   
Sleep disorder studies have been performed in several countries and it has been shown to 
effect men more than women. The prevalence of sleep disorders in North America, Europe, 
Australia, and Asia are not significantly different which suggests that this disease is common 
regardless of the development of the country (Cherasse, 2011; Franklin & Lindberg, 2015; 
Gottlieb, et al., 2010; Gharibeh & Mehra, 2010). 
Currently, there is a family clinic in the Southwestern United States that recently had a 
change in the organization and no longer has a sleep medicine provider.  A challenge that many 
clinics encounter is that there is no specific screening process in place for sleep disorders. There 
is not a specific clinical assessment or measurement that can diagnose sleep disorders but 
identifying those at risk helps the provider seek further evaluation by a sleep medicine provider. 
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Problem statement 
Lack of public awareness and provider education are some of the barriers to diagnosing 
and treating sleep disorders. The financial and physical consequences of undiagnosed sleep 
disorders in adult patients led to the clinical PICO question: In adult primary care patients, how 
does the use of a quality of sleep questionnaire compared to clinical judgement/current standard 
of care affect sleep disorder referral. 
Search Strategy and Methods 
To answer the PICOT question, the following databases were searched: Academic 
Premier (Appendix A), Cumulative Index of Nursing and Allied Health Literature (CINAHL) 
(Appendix B), and PubMed (Appendix C). Key words used to complete each search included: 
sleep disorders, screening, questionnaire, primary care, quality of life, cardiovascular, diabetes, 
hypertension, obstructive sleep apnea. The searches were conducted using publications dates 
from 2012-2018. Setting limits to English languages, regardless of country of origin, and 
combining terms produced over 535,426 articles.  
In total there were 63 articles that met the criteria and were retained for final review.  In 
addition to the search of the databases, the references of the selected articles were also examined 
for additional studies, however were excluded because they were not published between 2012 – 
2018. A search of grey literature was conducted and included position papers, practice 
guidelines, doctoral theses and dissertations, statistical reports and opinions papers but were 
excluded due to a low level of evidence. 
While reviewing the articles for inclusion, it can be noted that many of them had 
exclusion criteria that included pregnant subjects, a psychiatric diagnosis, non-English 
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publications and those that had participants under 18 years old. These exclusions were applied to 
this search as well to locate studies that demonstrated similar populations. Discarded 
publications consisted of those that had inconclusive evidence or misleading conclusions. Studies 
included had settings in a primary care office, specialty clinic or hospital, had a focus on either 
hypertension or diabetes and had screenings tools implemented or validated. Critical appraisal of 
47 articles yielded 10 publications that best addressed the PICOT question. These publications 
evaluated the relationship between sleep disorders and cardiovascular disease or diabetes. 
(Appendix E).    
Critical Appraisal and Synthesis 
 Ten studies have been chosen in this literature review, all studies were evaluated using a 
rapid critical appraisal and are presented in the evidence table for analysis of data (Appendix D). 
There was very little evidence to support screening or screening tools for sleep disorders in a 
primary care provider’s office. To overcome this challenge, the literature collected focused on 
current screening questionnaires that would identify a person who is at risk for a sleep disorder. 
The final studies for inclusion were comprised of two meta-analysis’s (MA), one randomized 
controlled trial (RCT), one systematic review (level of evidence (LOE) I), one experimental 
study (LOE III), two cross sectional studies (CSS) (LOE IV) and three cohort studies (CS) (LOE 
IV) (Appendix D).  It should be noted that the LOE I studies were not specific in the type of 
studies that were analyzed but they did have participants from various countries, solidifying how 
prevalent sleep disorders are regardless of region. Although level IV evidence is considered 
moderately strong, two of the studies could identify that sleep disorders increase the risk of DM 
and HTN complications. Overall there was moderate amount of homogeneity in the population, 
the majority were men and over the age of 50 years old.  This could be considered a weakness, 
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however epidemiological facts of sleep disorders state that males are more affected than females 
(Franklin & Lindberg, 2015). The samples size of the studies ranged from 200 to 47,978 
participants with an age range of 30-63 years old.  There was one study that had an outlier 
otherwise the average age would have bene closer to 50-63 years old.  
Seven of the studies either used or reviewed the screening questionnaires to identify if the 
severity of sleep disorders can be detected (Appendix D). In all, there were significant 
implications to indicate a screening tool was reliable in a hospital or surgical setting. Studies 
chosen were from different countries but all were in English and were published between 2012-
2018 (Appendix E). Theoretical frameworks were not listed in any of the studies but the most 
common theoretical framework that could be applied is Pender’s Health Promotion Model 
(Appendix F) and Lewin’s Change Theory (Appendix G). 
Most of the settings were surgical centers or hospital.  This is also where the participants 
were recruited from. There were two exceptions, one was an experimental study that took place 
in a primary care provider’s clinic and one cohort study was a longitudinal study that used the 
participants home for assessment. This could be considered a limitation because it was not 
generalizable to the other studies, however this study supported the need for the implementation 
of sleep disorder screening in a PCP setting.  
Homogeneity was present in the measurement tools used which consisted of the Berlin 
Questionnaire (BQ), STOP-Bang questionnaire (SBQ), STOP questionnaire (STOP) and the 
Epworth Sleepiness Scale (ESS). Sensitivity and specificity in the BQ, SBQ, STOP and ESS 
were noted in some of the studies. If the instrument used did not have the sensitivity and 
specificity noted in the article, it used one of the well-known instruments that has specificity and 
sensitivity published and verified. The evidence presented suggests that the SBQ had the highest 
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sensitivity and specificity among the screening questionnaire’s when the apnea-hypopnea index 
(AHI) was >5. The SBQ is also cost effective and has a simple format (Appendix H).  
Four of the studies used quality of life questionnaires before and after sleep disorder 
treatment.  The Functional Outcomes of Sleep Questionnaire (FOSQ) measures the impact of 
daytime sleepiness on activities of daily living using five subscale that include general 
productivity (concentrating and remembering), activity level (relationships affected, acting in the 
morning and evening), vigilance (watching movies, driving long and short distances), social 
outcomes and intimacy and sexual relationships (Weaver, et al., 1997).  The original 
questionnaire consisted of 30 questions, but in 2009 it was revised to a short 10 question form 
that still included the subscales of the original questionnaire with an internal consistency of α .87 
and would take less than 5 minutes to complete (Chasens, Ratcliffe, & Weaver, 2009). 
Purpose and Rationale 
The purpose of this evidence-based project is to identify if quality of sleep affects 
functional outcomes. Primary care providers can identify those who are at risk for sleep disorders 
based on their body mass index more than 30 (BMI >30) or diagnosis of HTN or DMII. 
Screening can be completed in the office using a questionnaire. Guidelines that are in place to 
screen for sleep disorders are recommendations intended for surgical candidates. There is no 
current recommendation for primary care providers which may prove to be a limitation, however 
these questionnaires may easily be generalized to a primary care outpatient setting due to the 
validity and reliability. The research provided can assist in detecting patients who may be at risk 
for sleep disorders based on a medical diagnosis of DM or HTN and obesity. The treatment of 
sleep disorders has been shown to reduce the risk of the chronic health consequences of 
untreated sleep disorders (Kapur, et al., 2017; Peach, Gaultney, & Reeve, 2015). The change in 
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practice would be to use a screening tool to detect sleep disorders earlier.  The benefit would be 
that an early diagnosis could decrease complications associated with diabetes and hypertension. 
The increased benefit of this screening program would include how it could potentially affect 
other aspects of the patient’s life.  
Conceptual Framework and Evidence Based Practice Model 
 The Health Promotion Model (HPM) (Appendix F) will guide the proposed change in a 
primary care office. It is focused on achieving a higher level of wellbeing and self-actualization. 
Individuals want to actively be involved in their care and continually make decisions based on 
their environment to improve their health. This model notes that each person has unique personal 
characteristics and experiences that affect actions and there are modifiable factors that can affect 
the behavior (Galloway, 2003).  Health care providers can influence the commitment and 
engagement of health promoting behaviors.  It is beneficial to provide support and assistance to 
achieve the desired outcome (Pender, 2011). 
 The Rosswurm and Larrabee Model (Appendix I) will be used to execute this proposed 
practice change. This framework uses six steps to implement and support a change in practice. 
Identifying the need for change (sleep disorder screening, identifying a sleep disorder) would 
initially include a combination of internal (identifying sleep disorder) and external data (effects 
of sleep disorder on DM and HTN) and how it would affect stakeholders (provider, staff and 
patients). This data would be used to identify interventions (sleep disorder screening) and guide 
the literature search to design the practice change (sleep disorder screening) and define desired 
outcomes (decrease complications from DM and HTN, improve quality of life). This initial study 
will be conducted to evaluate the process (screening), identify a need for practice change or 
process improvement and identify education needs (Rosswurm & Larrabee, 1999).  
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Project Methods 
This initiative was implemented using a qualitative approach with a descriptive 
methodology at a community health clinic.  Patients already scheduled with the provider were 
used as an opportunity for recruitment.  Inclusion criteria were individuals over 18 years old, 
BMI over 30, HTN or DMII, and write and speak in English. Exclusion criteria were those who 
are unable to consent and pregnant women. The Functional Outcomes of Sleep Questionnaire 
(FOSQ-10), was given to every candidate after a signed consent was completed, the 
questionnaire included demographic information (Appendix J). Demographic information 
consisted of age, gender, marital status, sleep alone, employment, race, insurance type, how 
many times does the person wake up at night, average number of hours of sleep and do they 
work night shift.  Due to time limitations, recruitment was conducted over three business days 
and 20 surveys were obtained. There was not any additional cost to participate in the survey and 
all candidates were voluntary without compensation.  
Project Results 
Descriptive statistics were conducted using SPSS to summarize study sample 
characteristics. Mann-Whitney tests were used to examine whether the total score of FOSQ-10 
was significantly different by demographic and health-related variables. The age of participants 
ranged from 33 to 72 years (M=50.1, SD= 11.32).  More than half of the sample was female 
(60%) and married/living with partner (60%). Despite being married/living with partner, half of 
the sample slept alone (50%). Half of the sample were white and employed (50%). Less than half 
of the participants had Medicaid (AHCCCS) (45%). The average numbers of times a person 
woke up was 2 (M=2.05, SD=1.25). The average number of hours slept per night was 6.6 hours 
(M=6.63, SD=1.54). Nearly all of the working participants, did not work at night (95%). More 
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than half of the sample had HTN (55%), most of the participants did not have DMII (80%) and 
most of the participants had a BMI>30 (85%). Out of the 20 surveys, the total score for questions 
1-10 (Q) had a maximum of 20 and minimum of 13.67 (M 17.02, SD = 1.97) Subscales has a 
maximum of 4 and minimum of 1.l Subscales for general productivity included concentrating 
(Q1) and remembering (Q2), with a maximum 4.00 and minimum of 2.00 (M = 3.50, SD = 0.67). 
Subscale activity included relationships affected (Q3), activity in the morning (Q4), activity in 
the evening(Q5), maximum of 4.00 and minimum of 3.00 (M = 3.77, SD = 0.34). Subscale 
Vigilance driving short distances (Q6), driving long distances (Q7), watching movies (Q8), 
maximum 4.00 and minimum of 2.67 (M = 3.50, SD = 0.41). 
The demographic portion of the questionnaire had categories with only one case. Those 
categories were merged to generate more meaningful data and interpretation of the FOSQ-10 
total score and demographics. A Mann-Whitney test on the recoded data showed statistical 
significance.  People being married/significant other had significantly lower total score of 
FOSQ-10 compared to not being married significant other (M = 6.25 vs M = 13.3, U = 14.0, p = 
.008). In other words, people being married/significant other had less functional disability than 
individuals not being married/significant other. Sleeping alone had a higher total score compared 
to those who did not sleep alone (M = 13.70 vs. M = 7.30, U=18.0, p = .015), meaning that 
individuals sleeping alone has less functional disability than those who do not sleep alone.  
Questions on the FOSQ-10 also had categories with only one answer, those one answers 
were recoded to determine if significance was present. Individuals with little to extreme 
difficulty in concentrating showed a lower total score compared to those with no difficulty in 
concentrating (M = 6.29 vs. M = 12.77, U=16.0, p = .019). Those who had little difficulty 
remembering had a lower score compared to those with no difficulty remembering (M = 6.38 vs. 
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M = 13.256, U = 15.0, p = .011). Individuals with a little too extreme difficulty being as active in 
the morning had a lower score than those who had no difficulty (M = 7.30 vs. M = 13.90 U 16.0, 
p = .009).  The category for little to extreme difficulty desire for intimacy had a lower total score 
than those who had no difficulty (M = 6.60 vs. M = 14.40, U = 11.0, p = .003).  
Discussion 
The increased benefit of a sleep disorder screening would include how it would affect 
other aspects of the patient’s life that include personal relationships, job performance and mental 
health (Park, Yoo, & Bae, 2013). Literature already presented for sleep disorders identified how 
it can affect comorbidities; increased HbA1c, uncontrolled HTN, obesity. In addition, health care 
professionals are part of this change and can provide education and guidance for well informed 
decisions to be made that could affect HTN and DM outcomes.  
In a study by Lou et al (2015) poor sleep and DMII impacted quality of life and 
suggested that screening for sleep disorders can influence sleep quality in diabetic patients. 
Evidence based literature also supports that quality of sleep correlates with body size and 
composition, cardiovascular health, and poor glycemic control (Bani-issa, Al-Shujairi, & Patrick, 
2018; Bruno, et al., 2013; Lou, et al., 2014). 
The FOSQ-10 may serve a role in identifying patients who might benefit from a sleep 
evaluation.  Time was a factor to consider, a major strength of the study is the FOSQ-10 was 
only ten questions and patients were able to complete the questionnaire in less than five minutes. 
Patients did not have to be recruited from an outside source, they were already at the clinic for 
another medical reason increasing the chances of capturing data.  
A limitation to the study was the lack of a sleep disorder screening tool, for example the 
SBQ, ESS or a validated tool that is specific to sleep disorders. In this study the SBQ was 
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removed due to proprietary reasons, the inclusion of a sleep disorder screening tool may increase 
the specificity and sensitivity of the intervention and the ability to yield data that will objectively 
measure disordered sleep. The FOSQ-10 could be used before and after treatment if a sleep 
provider determined a sleep treatment is necessary, thereby measuring how treatment affected 
quality of sleep and functional outcomes.  
Time was also a consideration, as noted by two potential participants who declined to 
participate, the appointments are for 20 minutes and this includes the time the medical assistant 
uses for the intake process which can take up to five minutes to complete. Candidates did not like 
the idea of going to another provider at a different clinic, nor did they want to spend the night at 
a facility if they were required to complete a sleep study. The cost associated with seeing a 
specialty provider was not as big of a factor to participate in the questionnaire.  
In this sample it is evident that marriage/significant other can influence sleep quality and 
the functional outcomes. Sleeping alone also affected sleep quality, factors to consider are 
whether the partner snores or has a movement disorder that disrupts the partners sleep. 
Individuals that did have lower total FOSQ-10 scores had little to extreme difficulty compared to 
those who had no difficulty. This is opposite of expectation, but this was also only a small 
sample of the population and it may warrant more education regarding sleep disorders and how 
to identify them. To better serve the clinic, a larger sample that more closely relates to the target 
population would provide a better description of sleep and how it affects functional outcomes.  
There is a need for further research to test the complete screening procedure with 
participants more closely matched with the target population: male, hypertension, diabetes 
mellitus II, obesity. Interventions for sleep disorders that address cultural and socioeconomic 
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barriers could also be evaluated that would include education and resources for low income and 
vulnerable populations.  
Conclusion 
 This qualitative approach with a descriptive methodology evidence-based project used a 
quality of life questionnaire that contained ten questions to measure the impact of daytime 
sleepiness on activities of daily living.  The FOSQ-10 was brief and simple to complete, most of 
the participants agreed to complete the questionnaire, but the sample size was also smaller than 
expected.  Although identifying functional limitations cannot predict a sleep disorder, it can help 
a provider identify a patient that requires further evaluation. 
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
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Table 1 
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Framework 
Design/ 
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Sample/ 
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Variables & 
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Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence; 
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practice/ 
application to 
practice 
 
Chiu (2017) 
Diagnostic 
accuracy of the 
Berlin 
questionnaire, 
STOP-BANG, 
STOP, and 
Epworth 
sleepiness scale 
in detecting 
obstructive 
sleep apnea: A 
bivariate meta-
analysis 
 
Country: 
United States & 
Taiwan 
 
Funding: 
Ministry of 
Not stated: Lewin’s 
Change Theory can 
be applied 
Design: MA                   
 
 
Purpose: 
Estimate the 
summary 
sensitivity, 
specificity and 
DOR of BQ, 
SBQ, STOP 
and ESS against 
AHI or RDI 
(severity of 
OSA)   
N: 100             
 
Demographics: 
Avg age 
BQ - 51.7 y  
SBQ – 55.5 y 
STOP – 50.8 y 
ESS – 52.3 y  
 
Inclusion 
criteria: 
Studies 
examining 
sensitivity and 
specificity of 
BQ, SBQ, 
STOP and ESS 
against AHI or 
RDI      
Access to full 
text in English 
IV1: BQ 
IV2: SBQ 
IV3: STOP 
IV4: ESS 
 
DV1:  dx of 
OSA 
DV2: Mild 
OSA AHI >5 
DV3: 
Moderate 
OSA AHI 
>15 DV4: 
Severe OSA 
AHI >30                                                                                                         
BQ 
SBQ 
STOP 
ESS 
 
Data extraction 
forms 
QUADAS-2 
 
Bivariate 
statistical 
analysis. 
 
Metaregression 
and moderator 
analysis 
 
Stata Version 
14.0 with midas 
and metandi 
user written 
command and
SAS version 
9.0.2 with Proc 
Mixed module 
 
Chi squared test  
 
Pooled sensitivity  
 (95% CI)  
AHI >5 
BQ (n=32) 0.76 
(0.71-0.81)  
SBQ (n=27) 0.88 
(0.83-0.91) 
STOP (n=10) 0.87 
(0.81-0.92) 
ESS (n=15) 0.54 
(0.45-0.63) 
 
AHI>15 
BQ (n=34) 0.77 
(0.73-0.81)
SBQ (n=32) 0.90 
(0.86-0.93) 
STOP (n=12) 0.89 
(0.81-0.94) 
ESS (n=8) 0.47 (0.35-
0.59) 
Level: 1 
 
Strengths: 
Large sample 
 
Weaknesses: 
Blinding and 
test 
reproducibility 
were not fully 
reported, can 
alter reliability. 
Heterogeneity 
among studies. 
Diagnostic 
properties of the 
questionnaires 
for certain 
population were 
unavailable. 
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
Science and 
Technology 
 
Bias: None 
 
 
or Chinse 
published in a 
peer reviewed 
journal. Or 
portable 
monitoring 
Full overnight 
in lab PSG, in 
home PSG 
 
 
Exclusion 
criteria: Non- 
English or 
Chinese text, 
not published in 
peer reviewed 
journal, 
children, 
adolescents, 
pregnant 
women  
 
 
  
AHI >30 
BQ (n=19) 0.84 
(0.79-0.88)  
SBQ (n=26) 0.93 
(0.89 -.95) 
STOP (n=10) 0.90 
(0.84 -0.93) 
ESS (n= 6) 0.58 
(0.48-0.67) 
 
Pooled specificity 
AHI >5 (95%CI)  
BQ (n=32) 0.59 
(0.48-0.66)  
SBQ (n=27) .42 (0.35 
-0.50) 
STOP (n=10) 0.42 
(0.29-0.56) 
ESS (n=15) 0.65 
(0.57-0.72) 
 
AHI >15 BQ  
BQ (n=34) 0.44 
(0.38-0.51)  
SBQ (n=32) 0.36 
(0.29 -0.44) 
STOP (n=12) 0.32 
(0.19-0.48) 
ESS (n=8) 0.62 (0.56-
0.68) 
 
AHI >30 
BQ (n=19) 0.38 (0.31 
Conclusion:  
SBQ is superior 
for detecting 
mild, moderate, 
severe OSA.  
 
Inexpensive tool 
when PSG not 
available 
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
-0.56)  
SBQ (n=26) 0.35 
(0.28 -0.44 
STOP (n=10) 0.28 
(0.18 -0.40) 
ESS (n= 6) 0.60 
(0.53-0.68) 
 
Pooled DOR (95% 
CI) 
 
AHI >5 (95%CI)  
BQ (n=32) 4.30 
(2.96-6.24)  
SBQ (n=27) 5.13 
(4.25-6.29) 
STOP (n=10) 4.85 
(2.50-9.41) 
ESS (n=15) 2.18 
(1.39-3.40) 
 
AHI >15 BQ  
BQ (n=34) 2.68 
(2.19-3.29)  
SBQ (n=32) 5.05 
(3.65-7.00) 
STOP (n=12) 3.71 
(2.73-5.06) 
ESS (n=8) 1.45 (0.94-
2.24) 
 
AHI >30 
BQ (n=19) 3.10 
(2.57-3.73)  
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
SBQ (n=26) 6.51 
(5.05-8.40) 
STOP (n=10) 3.37 
(2.10-5.39) 
ESS (n= 6) 2.10 
(1.76-2.52) 
 
 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables & 
Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
practice/ 
application to 
practice 
 
Coman (2016) 
Obstructive 
Sleep Apnea 
Syndrome and 
the Quality of 
Life 
 
Country: 
Romania 
 
Funding: 
European social 
Fund through 
the Sectorial 
Operational 
Programme 
Human 
Resources  
Not stated: Health 
Promotion Model 
could be applied 
Design: CSS 
 
 
Purpose: 
Assess OSA 
patients QOL 
before and after 
therapy.  
n: 79 
 
Setting: Sleep 
Laboratory 
 
Inclusion 
criteria: 
Adults with 
OSA who have 
CPAP at home 
and consented. 
 
Exclusion 
Criteria: 
Subjects 
refused, mental 
or cognitive 
disorders 
IV: SAQLI 
 
 
DV: Any 
participant 
with an =or> 
MiOSA 
 
SAQLI 
 
3 months of 
CPAP treatment 
 
ESS was only 
used to measure 
daytime 
sleepiness 
 
Somnologia 
Studio 5.0 as 
scoring platform 
 
Manual of 
American 
Academy of 
Sleep Medicine 
MedCalc 
Statistical 
Software 
version 15.8 
 
When 
applicable: 
Paired-t test, 
Wilcoxon test or 
ANOVA. 
Between groups 
student t test, 
Mann-Whitney 
test 
 
Sig level .05 
IV on DV1: SAQLI 
pretreatment 
3.11+0.32, mean total 
post treatment 4.24 
+0.39 
 
Level: 4 
 
Strength: 
Patients already 
diagnosed with 
CPAP and 
aware of 
treatment. 
Objective data 
collected 
regarding 
compliance 
using CPAP 
compliance 
card. 
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
 
Bias: None 
 
 
 
 
Weakness: 
Specific 
population. 
Central apnea 
was not 
evaluated 
separately  
 
Conclusion: 
QOL is impaired 
by OSA 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables & 
Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
practice/ 
application to 
practice 
 
Silva (2016) 
Obstructive 
Sleep Apnea 
and Quality of 
Life: 
Comparison of 
the SAQLI, 
FOSQ and SF-
36 
Questionnaires 
 
Country: 
United States 
 
Funding: 
None stated: 
Pender’s Health 
Promotion Model 
can be applied 
Design: Cohort 
 
Purpose: 
Compare 
instruments to 
each other to 
assess whether 
they were able 
to detect 
differences in 
QOL among 
groups with 
different 
severities of 
OSA and 
n:884 
 
Setting:  
Sleep Heart 
Health Study 
 
Population: 
Participants 
from Tucson 
and 
Framingham 
sites of the 
Sleep Heart 
health Study 
that initially 
IV1: SAQLI 
 
IV2: FOSQ 
 
IV3: SF-36 
MCS 
 
IV4: SF-36 
PCS 
 
DV: OSA 
treatment  
 
Sleep Habits 
Questionnaire 
 
ESS 
 
SF-36 (MCS 
mental component) 
 
SF-36 (PCS 
physical 
component) 
 
FOSQ 
 
Stat SE version 
13.0 for 
windows 
 
Fisher’s 
chi-square test 
ANOVA 
Pearson’s 
correlations 
Multivariate 
linear regression 
models 
Spearman’s 
Sig level 0.05 
 
Total scores  
 
IV1 on DV: Total 6.0 
(.82). No OSA 6.0 
(.78), Mild-moderate 
OSA 6.0 (.83), SOSA 
5.8 (.8) 
 
IV2 on DV: Total 
11.5 (.82), No OSA 
53.8 (8.0) Mild-
moderate OSA 11.5 
(.84), SOSA 11.4 
(.91) 
 
Level: 4 
 
Strength:  
Cohort was part 
of longitudinal 
study resulted in 
high compliance 
because they 
knew 
importance of 
compliance 
 
Weakness:  
Participants 
from 
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
NHLBI grant 
HL 062373-
05A2 
 
Bias: None 
 
whether there 
were 
differences 
between 
genders 
completed the 
QOL 
instruments 
 
 
Inclusion 
criteria: 
Participated in 
original 
Framingham 
sites of the 
Sleep Heart 
Health Study. 
Completed 
QOL 
questionnaires 
in original 
Framingham 
study, live in 
Tucson 
 
 
Exclusion 
criteria: did not 
participate in 
Framingham 
study 
 
 
SAQLI IV3 on DV: Total 
54.0 (8.2), No OSA 
53.8 (8.0), Mild-
moderate OSA 54.4 
(8.4), SOSA 55.3 
(7.4) 
 
IV4 on DV: Total 
47.1 (10.8), No OSA 
48.5 (10.5), Mild-
moderate OSA 46.5 
(11.0), SOSA 45.1 
(10.3) 
 
 
 
 
 
 
 
 
 
 
longitudinal 
study, may not 
be 
representative of 
US adult 
population. 
Those who do 
not have OSA 
were also 
included in QOL 
questionnaire. 
QOL 
questionnaires 
are specific to 
different aspects 
of QOL, hard to 
compare when 
they are 
measuring 
different areas 
of life 
 
Conclusion: 
QOL poorer in 
females with 
SOSA.  
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables & 
Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
practice/ 
application to 
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
practice 
 
Miller (2015) 
Screening and 
assessment for 
obstructive 
sleep apnea in 
primary care 
 
Country: 
United States 
 
Funding: None 
 
Bias: None 
Not indicated but 
Lewin's Change 
Theory 
Design: NE SR 
 
 
Purpose: 
Evaluate the 
screening and 
assessment for 
OSA in primary 
care setting        
N: 17 
 
Setting: 14 
non-
experimental 
and 3 
experimental 
designs 
 
Inclusion 
criteria: 
English 
language, 
primary care 
setting/internal 
medicine, OSA 
screening 
process, 
compared 
screening tools, 
management of 
OSA 
 
Exclusion 
criteria: Sleep 
disorders other 
than OSA, 
pediatric 
patients 
 
 
IV: 
Screening of 
OSA in PCP 
office   
 
DV1: BQ 
DV2: ESS 
DV3: STOP 
DV4: SBQ  
SBQ, SB, ESS, 
STOP 
 
AASM clinical 
guidelines task 
force 
Cronbach's 
alpha 
 
Test-
retest reliability 
 
 
Reliability (95% CI)  
BQ: Cat 1 α = 0.92 
Cat 2 α = 0.63 
 
ESS α = 0.88 
 
STOP k = 0.93 
 
SBQ none reported 
 
SBQ 
Sensitivity/Specificity 
(95% CI) (AHI _ 15 
events/hr) 
0.54/0.97  
0.79 
(0.67, 0.88)/ 
0.51 
(0.41, 0.62)  
0.95 
(0.91, 0.98)/ 
0.07 
(0.01e0.24)  
PPV/NPV (95% Cl) 
(AHI _ 15 events/hr) 
PPV = 0.97  
0.51 
(0.42, 0.61)/0.78 
(0.67, 0.87)  
0.87 
(0.82, 0.91)/0.20 
 
Level:1 
 
Strengths: 
Screening tools 
identify at risk 
patients for OSA 
 
Weakness: Not 
all screening 
tools have been 
reported to be 
reliable and 
valid.  
 
 
Conclusion: A 
screening and 
assessment 
process in PCP’s 
office is lacking. 
PCP’s aware 
health effects 
but do not 
recognize or 
refer 
Need large 
scale, 
nationwide 
studies to assess 
implementation 
in PCP settings 
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
ESS 
Sensitivity/Specificity 
(95% CI) (AHI _ 15 
events/hr) 
0.39, 0.71  
0.76 
(0.69e0.82)/0.48 
(0.29, 0.68)  
PPV/NPV (95% Cl) 
(AHI >15 events/hr) 
0.91 
(0.85, 0.95)/ 
0.23 
(0.13, 0.36)  
 
SQ 
Sensitivity/Specificity 
(95% CI) (AHI > 15 
events/hr) 
0.74 
(0.62, 0.84)/0.53 
(0.43, 0.63)  
0.62/0.56  
0.95 
(0.89, 0.97)/0.26 
(0.11, 0.46)  
PPV/NPV (95% Cl) 
(AHI > 15 events/hr) 
0.51 
(0.41, 0.60)/0.76 
(0.64,0.85)  
0.89 
(0.84, 0.93)/0.41 
(0.18, 0.67)  
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
 
 
SBQ 
Sensitivity/Specificity 
(95% CI) (AHI > 15 
events/hr) 
0.93 
(0.84, 0.98)/0.43 
(0.33, 0.53)  
0.87, 0.43  
0.98 
(0.94, 0.99)/0.03 
(0.006, 0.19)  
PPV/NPV (95% Cl) 
(AHI > 15 events/hr) 
PPV/NPV (95% Cl) 
(AHI > 15 events/hr) 
0.52 
(0.43, 0.61)/0.90 
(0.79, 0.97)  
0.87 
(0.81, 0.91)/0.20 
(0.03, 0.71)  
 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables & 
Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
practice/ 
application to 
practice 
Tan (2016) 
Predicting 
obstructive 
sleep apnea 
Not stated: Pender's 
Health Promotion 
Model can be 
applied 
Design:  CS 
 
Purpose: 
Determine if 
Setting: 
Outpatient 
cardiology 
clinic - Brigham 
IV: SBQ  
 
DV1: 
MSOSA dx  
SBQ 
 
PSG type 3 
 
R V.3.2.1. 
 
General 
demographics 
IV on DV1:  
Prevalence 28.1% 
BMI >35 
BMI >30 BMI > 27.5 
Level:4 
 
Strengths:  
High NPV in 
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
using the 
STOP-Bang 
questionnaire in 
the general 
population 
 
Country: 
Malaysia 
 
Funding: 
FY2014 Health 
Services 
Research and 
Quality 
Improvement 
Grant of Ng 
Teng Fong 
General 
Hospital, 
Jurong Health 
Service 
 
Bias: None 
 
 
untreated 
severe OSA is 
associated with 
elevated 
ambulatory 
blood pressure 
in patients with 
high 
cardiovascular 
risk despite 
medical 
management 
and Women's 
Hospital, Case 
Medical Center, 
Johns Hopkins 
Medical Center, 
Veterans 
Affairs Boston 
Healthcare 
System 
 
Inclusion 
criteria: high 
risk for CV 
disorders. CAD 
>3 months 
prior, >3 CV 
risk factors 
(PCP treated 
HTN SBP 
>140mmhg or 
DBP >90mmhg 
or AHTN meds, 
DM, BMI, DLP 
 
BMI 27.5-30 
 
 
Exclusion 
criteria: HF 
with EF <30% 
or NYHA class 
>2, BP 
>170/100 
mmHg, HbA1c 
DV2: SOSA 
dx 
 
Time frame: 
7 months 
2012 AASM 
respiratory 
scoring 
 
World Health 
Organization 
cutoff to define 
obesity in Asian 
individuals 
 
 
 
Anthropometrics 
 
Sn: 66.2, 73%, 70.1% 
Sp: 74.7%, 73.0%, 
70.1% 
PPV: 50.6%, 50.0%, 
48.0% 
NPV: 85%, 85.8%, 
86% 
ROC: 0.704, 0.711, 
0.704 
 
IV on D2 
Prevalence 10.7% 
BMI >35 
BMI >30 BMI > 27.5 
Sn: 69.2, 73.1%, 
73.1% 
Sp: 67.1%, 65.3%, 
62.5% 
PPV: 20.2%, 20.2%, 
19.0% 
NPV: 94.8%, 95.3%, 
95.1% 
ROC: 0.682, 0.692, 
0.678 
 
SBQ 
 
Weakness: 
Portable sleep 
studies used 
instead of in lab 
PSG. 
NPV could be 
inflated due to 
underestimation 
of portable 
monitors. 
Oversampled 
snorers.  
 
Conclusion: 
SBQ can be 
used as a 
screening tool to 
prioritize 
individuals for 
further testing. 
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
>9%, prior 
stroke with 
functional 
impairment, 
severed 
uncontrolled 
medical 
problems, 
medications 
that 
 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables & 
Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
practice/ 
application to 
practice 
Walia (2014) 
Association of 
severe 
obstructive 
sleep apnea and 
elevated blood 
pressure despite 
antihypertensive 
medication use 
 
Country: 
United States 
 
Funding: None 
 
Bias: None 
Not stated: Pender’s 
Health Promotion 
Model can be used 
Design:  CS 
 
Purpose: 
Determine if 
untreated 
severe OSA is 
associated with 
elevated 
ambulatory BP 
in patients with 
high CVD risk 
despite medical 
management 
n: 284 
 
Demographics: 
M age: 63.1 + 
7.2 CBP=SBP 
<130 and DBP 
<80. 
EBP=SBP>130 
or DBP >80 
WIAR, 
WOIAR, REBP 
WIAR, UEBP 
WIAR 
 
 
Setting: 
Outpatient 
IV: OSA  
 
DV1: CBP 
WOIAR  
DV2: CBP 
WIAR  
DV3: EBP 
REBP WIAR  
DV4: EBP 
UEBP 
WOIAR  
DV5: WIAR 
CBP  
DV6: WIAR 
REBP 
DV7: 
WOIAR 
AASM 2007 
guidelines 
 
Spacelabs 90217 
Ambulatory 
Blood Pressure 
Monitors  
 
Measure BP 
every 20 minutes 
from 0600-2200 
and every 30 
between 2200-
0600 for 24hr 
period 
 
Resting BP after 
Univariate and 
multivariable 
logistic 
regression  
 
Kruskal-Wallis 
test 
 
SAS version 9.2  
p<0.05 
 
IV on DV1: 45.8% 
 
IV on DV2: 15.8% 
 
IV on DV3: 9.9% 
 
IV on DV4: 28.5% 
 
IV on DV5: 15.8% 
 
IV on DV6: 9.9% 
 
IV on DV7: 45.8% 
 
IV on DV8: 28.5% 
Level:4 
 
Strengths: 
Multiple clinical 
settings (makes 
more general) 
24 ambulatory 
BP monitoring 
is more reliable 
than spot office 
BP 
measurements 
 
Weakness: No 
ability to 
compare those 
without sleep 
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
cardiology 
clinic - Brigham 
and Women's 
Hospital, Case 
Medical Center, 
Johns Hopkins 
Medical Center, 
Veterans 
Affairs Boston 
Healthcare 
System 
 
Inclusion 
criteria: high 
risk for CV 
disorders. CAD 
>3 months 
prior, >3 CV 
risk factors 
(PCP treated 
HTN SBP 
>140mmhg or 
DBP >90mmhg 
or AHTN meds, 
DM, BMI, DLP 
 
Exclusion 
criteria: HF 
with EF <30% 
or NYHA class 
>2, BP 
>170/100 
mmHg, HbA1c 
>9%, prior 
CBP  
DV8: 
WOIAR 
UEBP 
 
sitting quietly for 
>5 minutes 
 
JNC7 guidelines 
apnea. 
Not able to 
assess if those 
with MiOSA or 
MOSA with 
those without 
OSA. 
Medication 
dosages, 
compliance info 
not available.  
 
Conclusion: 
There is an 
association of 
untreated SOSA 
and REBP.  
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
stroke with 
functional 
impairment, 
severe 
uncontrolled 
medical 
problems, 
medications 
that might 
influence 
measurements 
or impair ability 
to participate 
 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables & 
Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
practice/ 
application to 
practice 
Wang (2013) 
Obstructive 
sleep apnoea 
and the risk of 
type 2 diabetes: 
A meta-analysis 
of prospective 
cohort studies 
 
Country: China 
 
 
 
Funding: 
None stated: 
Pender’s Health 
Promotion can be 
used 
Design: MA 
 
 
Purpose: 
Assess the 
association 
between the 
severity of OSA 
and the risk of 
type 2 diabetes 
N: 6 
 
n: 5953 
 
Setting: LR 
using Meta-
analysis of 
Observational 
Studies in 
Epidemiology 
group 
 
Inclusion 
criteria: 
IV: Risk of 
DM 
 
DV1: MOSA 
DV2: 
MSOSA 
 
Time frame: 
follow up 
period 2.7-16 
years 
 Stata version 
11.2 
 
Publication bias: 
Begg’s test and 
Egger’s test.  
Heterogeneity: 
Cochrane Q-test 
and I2 test 
 
P < 0.10 
RR of DM for those 
with MSOSA 1.63 
(95% CI: 1.09-2.45, P 
= 0.018) 
 
Pooled risk estimate 
MiOSA and DM 1.22 
(95% CI: 0.91-1.63, P 
= 0.193) 
 
 
Level:1 
 
Strengths: All 
studies used 
objective 
measurements.  
 
Defined the 
severity of OSA 
according to 
AHI and ODI. 
 
Weakness: 
Definitions of 
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
Shandong 
Province 
Natural Science 
Foundation of 
China 
 
Bias: None 
 
prospective 
cohort studies 
OSA was 
assessed with 
objective 
measurements. 
OSA and the 
outcome of 
interest was 
DM 
 
Exclusion 
criteria: CSS, 
LR and studies 
that used self 
reported 
surrogate 
parameters 
 
OSA were not 
uniform. 
 
Influenced by 
referral bias 
(false 
impression of 
the significance 
of association 
with DM) 
 
Methods to dx 
DM were 
different for 
each study 
 
Conclusion: 
MSOSA 
increases the 
risk of DM, 
risks increase 
with severity of 
OSA 
 
Citation Theory/Conceptual 
Framework 
Design/Method Sample/Setting Major 
Variables & 
Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence: 
Decision for 
practice/ 
application to 
practice 
Wang (2016) 
Association of 
obstructive 
sleep apnea plus 
None stated: 
Pender's Health 
Promotion can be 
applied 
Design: CSS 
 
Purpose: To 
evaluate the 
n: 1889  
 
Setting: 
Inpatient 
 
IV: OSA 
 
DV1: HTN  
 
 
Log for 
statistical 
analysis 
 
IV on DV1: HTN no 
OSA (OR: 1.808, 
95% CI: 1.207-2.707) 
HTN with MiOSA 
Level: 4 
 
Strengths: 
Large sample 
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
hypertension 
and prevalent 
cardiovascular 
disease 
 
Country: China 
 
Funding: Not 
stated 
 
Bias: None 
association of 
OSA plus HTN  
cardiovascular 
ward  
n=773 
Normotension 
M age 54.7 + 
12.4 Male: 570 
n=1116 HTN M 
age 58.7 + 11.9 
Male: 841 
 
Inclusion 
criteria: pt 
agreed to 
participate, 
spouses 
reported 
snoring during 
sleep, no 
previous OSA 
dx 
Exclusion 
criteria: pt did 
not agree, 
previous OSA 
dx 
 
 
1-way ANOVA  
 
Mann-Whitney 
U 
 
Chi-square 
 
Fisher exact test 
 
Logistic 
regression 
analysis 
 
SPSS 18.0 
 
P < 0.05 
(OR: 2.003, 95% CI: 
1.346-2.980) 
HTN with MSOSA 
(OR: 1.834, 95% CI: 
1.214-2.770) 
 
size. 
All participants 
were from the 
same ward. 
Standard and 
similar BP 
methods were 
used on all 
participants. 
 
Weakness: 
HTN patients 
were older in 
age. 
Blood pressure 
used was at 
admission, this 
could have been 
elevated due to 
white coat 
syndrome. 
 
Conclusion: 
There may be a 
synergistic 
adverse effect of 
OSA and HTN 
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables & 
Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
practice/ 
application to 
practice 
Weaver (2012) 
Continuous 
positive airway 
pressure 
treatment of 
sleepy patients 
with milder 
obstructive 
sleep apnea: 
Results of the 
CPAP apnea 
trial north 
American 
program 
(CATNAP) 
randomized 
clinical trial 
 
Country: U.S. 
 
Funding: 
National 
Institutes for 
Health, National 
heart, Lung and 
Blood Institute, 
Sleep Medicine 
Education and 
None stated: Can 
use Pender’s Health 
Promotion Model 
Design: RCT 
 
Purpose: 
Evaluate 
efficacy of 
CPAP to 
improve 
functional 
status in sleep 
patients with 
MiOSA and 
MOSA 
n:223 
 
Setting: Active 
or Sham CPAP 
for home use 
randomized to 8 
weeks of study 
at home 
 
Inclusion: New 
diagnosis of 
MiOSA, no 
previous CPAP 
use, stable 
medically for 4 
months, no 
history of sleep 
disorders, 
pregnancy, 
substance use, 
sleepiness 
related driving 
accident or 
sleepiness 
sensitive 
occupation 
 
 
IV: OSA 
 
DV1: 
Sham CPAP 
 
DV2: Active 
CPAP 
ESS to measure 
sleepiness 
 
SF-36 
Psychomotor 
Vigilance task 
 
Total Mood 
Disturbance Scale 
on the Profile of 
Moods States,  
 
Mean 48 hour 
ambulatory blood 
pressure 
 
FOSQ 
Last 
Observation 
Carried Forward 
 
 
Paired t tests 
 
Effect size 0.36 
 
Sig 0.05 
 
 
Baseline 
IV on DV1: FOSQ 
total score 13.91 + 
3.02 
 
IV on DV2: FOSQ 
total score 14.43 + 
2.78  
(P=0.18) 
 
 
Final treatment 
mean change 
IV on DV1: FOSQ 
-0.06  
 
IV on DV2: FOSQ 
0.89  
(p = .0006) 
 
Adjusted difference 
in mean changes (SE) 
0.95 (0.34) 
 
Lower and upper 
95% CI 0.27, 1.62 
 
Level:1 
 
Strength: Large 
sample size. 
Low dropout 
rate 
 
Weakness: 
mean daily 
CPAP use was 4 
hours and 3 
hours per day, 
desired 6 hours 
of use. 
Multisite double 
blind RCT that 
is first of its 
kind. 
 
 
Conclusion: 
CPAP therapy 
for sleep patient 
with milder 
OSA can have 
significant 
health benefits 
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
Research 
Foundation, 
Respironics 
Sleep and 
Respiratory 
Research 
Foundation, 
Cepahlon, Inc 
 
Bias: 
Equipment 
provided but 
does not say if 
compensation 
or if was given 
in the form of a 
grant 
 
 
Exclusion: 
Those that did 
not meet 
inclusion 
criteria 
 
Citation Theory/ 
Conceptual 
Framework 
Design/ 
Method 
Sample/ 
Setting 
Major 
Variables & 
Definitions 
Measurement/ 
Instrumentation 
Data Analysis 
(stats used) 
Findings/ 
Results 
Level/Quality 
of Evidence; 
Decision for 
practice/ 
application to 
practice 
Williams (2017) 
Implementation 
of an 
obstructive 
sleep apnea 
screening 
program at an 
overseas 
military hospital 
Not stated: 
Lewin's Change 
Theory can be 
applied 
Design: 
experimental 
 
Purpose: 
Determine 
whether 
educating 
nurses on OSA 
and 
n: 200 
 
Setting: U.S. 
Naval Hospital 
in Okinawa, 
Japan 
 
Inclusion 
criteria: All 
IV: 
Education 
regarding 
OSA 
screening 
using SBQ 
 
DV1: 
increase 
Education OSA 
(PowerPoint 
presentation) 
 
Descriptive 
statistics 
 
2 test  
 
 
P = .05 
 
IV on DV1: 1.18 + 
1.02 vs 0.91 + 0.68 
(P = .03) 
 
IV on DV2: 5% to 26 
% (P = .0001) 
Level:3 
 
Strengths: 
Findings 
significant to 
identify those at 
risk for OSA, 
decrease 
perioperative 
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Key:   AC – Accuracy, AASM – American Academy of Sleep Medicine, AHTN – antihypertensive, AHI – apnea-hypopnea index, AVG – average, BMI – body max index, BP – blood pressure, BQ – 
Berlin questionnaire,  CV – cardiovascular, CVD – cardiovascular disease,  CBP – controlled blood pressure, CI – confidence interval, CAD – coronary artery disease, , CS – cohort study, CSS – cross 
sectional study,  DBP - diastolic blood pressure, DOR – diagnostic odds ratio, DLP – dyslipidemia, DM – diabetes mellitus, DV- dependent variable, dx - diagnosis, EBP – elevated blood 
pressure, EF – ejection fraction, EHR – electron health record, ESS – Epworth sleepiness scale, FOSQ- Functional Outcomes of Sleep Questionnaire, HgA1c – glycated hemoglobin,  HF – heart 
failure, HTN – hypertension,  IAR – intensive antihypertensive regimen, IV- independent variable, LR – literature review,  M - mean , MA – meta-analysis, MiOSA – mild obstructive sleep apnea 
AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental,  Nuero – neurological, NPV – negative predictive value, N-number 
of studies; n- number of participants, NYHA – New York Heart Association, OR - odds ratio,  OS – observational study, OSA – obstructive sleep apnea, ODI – oxygen desaturation index, pt – 
patient,  PCP – primary care provider, PPV – positive predictive value, PSG – polysomnography, PRISMA – preferred reporting items for systematic reviews and meta-analysis, PSQI – Pittsburgh 
Sleep Quality Index, PSY – psychological, QOL- quality of life,  REBP – resistant elevated blood pressure, RDI – respiratory disturbance index, ROC – receiver operating characteristic, RR – relative 
risk, SAQLI – Calgary Sleep Apnea Quality of Life Index, SBQ – STOP-Bang questionnaire, SD – standard deviation, SF-36 – Short Form of the Medical Outcomes Survey, SOSA – severe sleep 
apnea AHI > 30, Sn - Sensitivity, Sp – Specificity, SR – systematic review, STOP – STOP questionnaire, SBP – systolic blood pressure, UEBP -uncontrolled elevated BP, WIAR – with intensive 
hypertension regimen, WOIAR – without intensive hypertension regiment 
 
Country: 
United States 
 
Funding; Not 
stated 
 
Bias: disclaimer 
study was 
independent of 
US Naval 
Department 
incorporating 
SBQ into the 
preoperative 
screening 
process was 
associated with 
an increase in 
Identification of 
pt with 
suspected OSA 
and increase in 
nurse generated 
anesthesia 
consults for 
OSA 
charts 
regardless of 
OSA dx 
 
Exclusion 
criteria: 
cesarean 
deliveries, 
younger than 18 
years, 
emergency 
surgery 
identification 
of suspected 
OSA 
 
DV2: 
Increase 
frequency of 
nurse 
generated 
anesthesia 
consults for 
OSA 
 
Time frame: 
1 month 
complications. 
 
Weakness: 
Older version of 
preop forms 
were used 
Inconsistent 
recording of 
apnea. 
symptoms. 
Type of surgery 
not listed. 
 
No PSG 
available for 
those who 
scored 3 or 
higher on SBQ 
 
Small sample 
 
Short timeframe 
 
Conclusion: 
Using the SBQ 
increased the 
identification of 
patients at high 
risk for OSA. 
Improve patient 
safety. 
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*Blank boxes indicate it was not applicable 
Key:  BQ – Berlin questionnaire, CS – cohort study, CSS – cross sectional study, DM – diabetes mellitus, , ESS – Epworth sleepiness scale, HTN – hypertension, LOE – level of evidence, MA – meta-
analysis, MiOSA – mild obstructive sleep apnea AHI >5 but <15, MOSA – moderate sleep apnea AHI >15 but <30, MSOSA – moderate-severe sleep apnea, NE – non-experimental, N-number of 
studies; n- number of participants,  OS – observational study, OSA – obstructive sleep apnea, PCP – primary care provider,  SBQ – STOP-Bang questionnaire, SOSA – severe sleep apnea 
AHI > 30, SR – systematic review, STOP – STOP questionnaire, + diagnosed.  
 
Appendix E 
Synthesis Table 
Author Chiu Coman Miller Silva Tan Walia Wang Wang Weaver Williams 
Year 2016 2015 2015 2016 2016 2014 2013 2016 2012 2017 
Study Design/Level of 
Evidence 
MA 
LOE: 1 
CSS 
LOE: 4 
SR 
LOE: 1 
CS 
LOE: 4 
CS 
LOE: 4 
CS 
LOE: 4 
MA 
LOE: 1 
CSS 
LOE: 4 
RCT 
LOE: 2 
Experimental 
LOE: 3 
Setting U.S./Chi
na 
Romania U.S. U.S. Malaysia U.S. China China U.S. U.S. 
PCP Office  x     x     
Hospital/Surgery Center x  x    x x  x 
Sleep Clinic x x x  x    x  
Home    x       
Sample Size           
N  79 17 884   6    
n 47978    242 284 5953  121/118 200 
Gender           
Male  59  421 122 207  1411 55%/63%  
Female  20  463 120 77  478   
Average Age in Years           
 52.5 54.13  61.6 48.3 63.1 30-69 54.7 49.5/51.7  
Screening Questionnaires           
SBQ x  x  x     x 
ESS x x x x x    x  
SQ x  x        
BQ x  x        
Detection of OSA           
MiOSA + + + +    + + + 
MSOSA + + + + + + + + + + 
SOSA + + + + + + + +  + 
Presence of            
HTN x  x  x x  x   
DM x  x  x x x x   
QOL Questionnaire  x  x x    x  
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Appendix F 
Pender’s Health Promotion Model
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Appendix G 
Lewin's Change Theory 
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Appendix H 
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Appendix I 
Rosswurm and Larrabee’s Model 
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Appendix J 
Demographics 
Please answer each question in the space provided 
 
1. Age: _________ 
 
2. Gender 
_____ Male _____ Female 
 
3. Marital Status 
 _____ Single 
 _____ Married/Living with Partner 
 _____ Divorced 
 _____ Widowed 
 
4. Do you sleep alone? 
 _____ Yes  _____ No 
 
5. Are you  
_____ Employed 
_____ Retired  
_____ Disabled  
_____ Student  
 
6. Race 
_____ White 
_____ Black or African American 
_____ Hispanic or Latino 
_____ American Indian or Alaska Native 
_____ Asian 
_____ Native Hawaiian or other Pacific Islander 
_____ Other 
 
7. Insurance 
 Medicare _____ 
 Medicaid (AHCCCS) _____ 
 Private Insurance _____ 
 No Insurance _____ 
 
8. On average, how many times do you wake up at night? ________ 
 
9.  What is the average number of hours you sleep per night?  _______ 
 
10.  Do you work night shift?  _____ Yes _____ No 
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FUNCTIONAL OUTCOMES OF SLEEP QUESTIONNAIRE (FOSQ) 
 
Some people have difficulty performing everyday activities when they feel tired or sleepy. The purpose of this questionnaire is to find 
out if you generally have difficulty carrying out certain activities because you are too sleepy or tired. In this questionnaire, when the 
words “sleepy” or “tired” are used, it means the feeling that you can’t keep your eyes open, your head is droopy, that you want to “nod 
off”, or that you feel the urge to take a nap. These words do not refer to the tired or fatigued feeling you may have after you have 
exercised. 
DIRECTIONS: Please put a Check Mark in the box for your answer to each question. Select only one answer for each question. 
Please try to be as accurate as possible. All information will be kept confidential. 
 
  (0) 
I don’t do this 
activity for 
other reasons 
(4) 
 No difficulty 
(3) 
Yes, a little 
difficulty 
(2) 
Yes, 
moderate 
difficulty 
(1) 
Yes, extreme 
difficulty 
1. Do you have difficulty concentrating on the things you 
do because you are sleepy or tired? 
     
2. Do you generally have difficulty remembering things, 
because you are sleepy or tired? 
     
 (0) 
I don’t do this 
activity for 
other reasons 
(4) 
No difficulty 
(3) 
Yes, a little 
difficulty 
(2) 
Yes, 
moderate 
difficulty 
(1) 
Yes, extreme 
difficulty 
3. Do you have difficulty operating a motor vehicle for 
short distances (less than 100 miles) because you become 
sleepy or tired? 
     
4. Do you have difficulty operating a motor vehicle for 
long distance (greater than 100 miles) because you become 
sleepy or tired? 
     
5. Do you have difficulty visiting with your family or 
friends in their home because you become sleepy or tired? 
     
6. Has your relationship with family, friends or work 
colleagues been affected because you are sleepy or tired? 
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(0) 
I don’t do this 
activity for 
other reasons 
(4) 
No difficulty 
(3) 
Yes, a little 
difficulty 
(2) 
Yes, 
moderate 
difficulty 
(1) 
Yes, extreme 
difficulty 
7. Do you have difficulty watching a movie or videotape 
because you become sleepy or tired? 
     
8. Do you have difficulty being as active as you want to be 
in the evening because you are sleepy or tired? 
     
9. Do you have difficulty being as active as you want to be 
in the morning because you are sleepy or tired? 
     
 (0) 
I don’t engage 
in sexual 
activity for 
other reasons 
(4) 
No 
(3) 
Yes, a little 
(2) 
Yes, 
moderately 
(1) 
Yes, 
extremely 
10. Has your desire for intimacy or sex been affected 
because you are sleepy or tired? 
     
 
 
